ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Kaleido ends oversubscribed funding round at $101m
pharmaceutical-technology
June 28, 2018Microbiome startup Kaleido Biosciences has closed its oversubscribed Series C financing round at $101m. Investment came from Fidelity Management, Invus, as well as a subsidiary of Abu Dhabi Investment Company and Flagship Pioneering, Kaleido’s founder.
Pharma Sources Insight January 2025
